Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)
PHASE4
Vitamin K antagonists (VKAs) are used to reduce the risk of stroke (cerebra...
Status
Unknown
Location
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine
Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.
PHASE2
The purpose of this study is to try to find the best dose of the new drug B...